IndraLab
Statements
Barium(2+) inhibits NLRP3. 32 / 32
|
32
reach
"Therefore, we speculate that the combination of MitA or other SP1 inhibitors and CPT-11 might achieve a startling effect of reducing the side effect and enhancing the anticancer efficacy simultaneously in the treatment of colorectal cancer.In inflammatory conditions, we show in this study that TGR5 participates in the inhibition of NLRP3 inflammasome by BA in vitro, while in vivo TGR5 was significantly promoted by OA, but not affected by CPT-11 and MitA treatments."